Provided by Tiger Trade Technology Pte. Ltd.

Adverum Biotechnologies

4.36
0.0000
Volume:- -
Turnover:- -
Market Cap:96.26M
PE:-0.51
High:4.36
Open:4.36
Low:4.36
Close:4.36
52wk High:6.07
52wk Low:1.78
Shares:22.08M
Float Shares:11.36M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.5585
EPS(LYR):-6.6185
ROE:-417.79%
ROA:-76.90%
PB:-1.73
PE(LYR):-0.66

Loading ...

Lilly and Adverum Announce Expiration and Completion of Adverum Tender Offer and Acquisition

THOMSON REUTERS
·
Dec 09

Press Release: Lilly and Adverum announce expiration and completion of Adverum tender offer and acquisition

Dow Jones
·
Dec 09

Adverum Biotechnologies CEO Laurent Fischer Reports Acquisition of Common Shares

Reuters
·
Dec 09

NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM

Reuters
·
Dec 09

Adverum Biotechnologies Files Initial Beneficial Ownership Statement for Frazier Life Sciences Public Fund

Reuters
·
Dec 06

10% Owner Braden Michael Leonard Reports Sale of Adverum Biotechnologies Common Shares

Reuters
·
Dec 04

BRIEF-Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly

Reuters
·
Dec 01

Adverum Biotechnologies Inc: Tender Offer Is Scheduled to Expire One Minute Past 11:59 P.m., Eastern Time, on December 8, 2025

THOMSON REUTERS
·
Dec 01

Adverum Reminds Stockholders to Tender Their Shares Into the Offer by Lilly

THOMSON REUTERS
·
Dec 01

Adverum Urges Shareholders to Accept Lilly Buyout Amid Imminent Liquidation Risk

Reuters
·
Dec 01

Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly

GlobeNewswire
·
Dec 01

Adverum Biotechnologies Faces Lease Termination Notice

TIPRANKS
·
Nov 22

BRIEF-Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing

Reuters
·
Nov 22

Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement, Dated Jan 8, 2021 With Adverum Biotechnologies - SEC Filing

THOMSON REUTERS
·
Nov 22

Adverum Biotechnologies Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Nov 17

HC Wainwright Downgrades Adverum Biotechnologies to Neutral From Buy, Price Target is $5

MT Newswires Live
·
Nov 17

Mizuho Securities Remains a Buy on Adverum Biotechnologies (ADVM)

TIPRANKS
·
Nov 17

Adverum Biotechnologies downgraded to Neutral from Buy at H.C. Wainwright

TIPRANKS
·
Nov 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 06

Adverum Biotechnologies Inc expected to post a loss of $1.58 a share - Earnings Preview

Reuters
·
Nov 03